Serotonin receptor contribution to inflammation-induced calcific aortic valve disease
血清素受体对炎症引起的钙化主动脉瓣疾病的贡献
基本信息
- 批准号:9903448
- 负责人:
- 金额:$ 39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-01 至 2023-03-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAffectAgonistAortic Valve StenosisApolipoprotein EAtomic Force MicroscopyAttenuatedBiomechanicsC57BL/6 MouseCalcium ChannelCardiovascular systemCell membraneCellsCholesterolCicatrixClinical ResearchComputersDiseaseElderlyEventFibrosisFluorescence MicroscopyGeneticGenetically Engineered MouseHeart ValvesHydrogelsHyperlipidemiaImageImplantIndividualInflammationInflammatoryLasersLeadLesionLightLinkMeasuresMechanicsMediatingMedicineModulusMorbidity - disease rateMusNoduleOsteogenesisPathogenesisPathway interactionsPatientsPeripheralPharmacological TreatmentPharmacologyPlayProcessPublic HealthReportingRoleSerotonergic SystemSerotoninSerotonin AgentsSerotonin Receptor 5-HT2BSerumSignal PathwaySignal TransductionStructureTNF geneTechniquesTechnologyTestingTimeUp-RegulationWild Type Mouseaortic valveaortic valve disorderbasebone morphogenetic protein 2calcificationcell typecytokineexperimental studyimplantationin vivoinflammatory milieuinhibitor/antagonistinnovationinsightinterstitial cellknock-downmRNA Expressionmineralizationmortalitymouse modelmutantosteoblast differentiationpreventreceptorserotonin receptorsubcutaneous
项目摘要
PROJECT SUMMARY/ABSTRACT
No pharmacological approach has been found to prevent/treat calcific aortic valve disease (CAVD), whose
pathophysiological changes include calcification and fibrosis, causing aortic stenosis, often in combination with
regurgitation. Evidence shows that pro-inflammatory cytokines are potent stimulators of cardiovascular
calcification, while the serotonergic system is a potent stimulator of fibrosis. In particular, serotonin receptor 2B
(SR-2B) activation is known to cause structural and mechanical changes in aortic valves, such as fibrosis and
thickening, in some cases, dense nodules, though not calcification. Clinical studies also show that serotonin (5-
HT) levels are almost twice as high in patients with aortic stenosis, and are significantly associated with
progression of aortic stenosis. These findings suggest that SR-2B activation also contributes to the
pathogenesis of inflammation-induced CAVD. Interestingly, as confirmed in our preliminary studies, the
predominant receptor subtype expressed in murine aortic valve interstitial cells, at baseline, is SR-2A, rather
than SR-2B. However, in our additional preliminary studies, we found that it was SR-2B that was dramatically
upregulated (> 30-fold) by TNF-a. This induction required BMP-2 signaling and may account for our findings
that, although 5-HT augmented TNF-a-induced calcification, it had no effect alone.. We also found that the
TNF-a/5-HT-induced calcification occurred via induction of Orai1, a plasma membrane calcium channel, and
this calcification was attenuated by specific inhibitors or knockdown of only SR-2B. Additional preliminary
studies show that circulating peripheral 5-HT levels were higher in hyperlipidemic (Apoe-/-) compared with wild
type mice, and SR-2B expression in the valve cusps was adjacent to cholesterol clefts and calcified lesions in
Apoe-/- but not in wild type mice. Based on the collective evidence, we hypothesize that 5-HT in the
hyperlipidemic milieu plays a key role in CAVD. We posit that hyperlipidemia increases circulating levels of
both 5-HT and inflammatory cytokines, the latter of which induce SR-2B and osteogenesis in valve cusps, and,
together, these events lead to CAVD. In Aim 1, we will determine receptor subtype-specific effects of 5-HT
on matrix mechanics under non-inflammatory (SR-2A dominant) as well as on calcification under inflammatory
(SR-2B dominant) conditions and on the signaling pathways mediating TNF-a induction of SR-2B and of
downstream osteoblastic differentiation. In Aim 2, we will determine whether 5-HT signaling via SR-2B is
critical for inflammation-induced CAVD using 1) a 5-HT-deficient, inflammatory mouse model (Tph1-/-Ldlr-/-
Apob100/100), and 2) receptor subtype-specific agonists and antagonists. We will apply cutting edge technology,
including laser light sheet fluorescence microscopy; serial in vivo fused 18F-µPET-µCT imaging; atomic force
microscopy; 3-D hydrogel cultures; and implantation of receptor subtype knockdown cells. The proposed
experiments will elucidate how 5-HT receptor subtype-specific signaling changes the structure of valve cusps
and whether targeting SR-2B opens the path for effective pharmacological-based treatment of CAVD.
项目总结/摘要
尚未发现预防/治疗钙化性主动脉瓣疾病(CAVD)的药理学方法,
病理生理变化包括钙化和纤维化,导致主动脉瓣狭窄,通常与
返流程度有证据表明,促炎细胞因子是心血管疾病的有效刺激因子,
钙化,而肾上腺素能系统是纤维化的有效刺激物。特别是血清素受体2B
已知SR-2B激活引起主动脉瓣的结构和机械变化,例如纤维化和纤维化。
增厚,在某些情况下,致密的结节,虽然没有钙化。临床研究还表明,血清素(5-
HT)水平几乎是主动脉瓣狭窄患者的两倍,并且与
主动脉瓣狭窄的进展。这些发现表明,SR-2B激活也有助于
炎症诱导的CAVD的发病机制。有趣的是,正如我们的初步研究所证实的那样,
在基线时,鼠主动脉瓣间质细胞中表达的主要受体亚型是SR-2A,而
比SR-2B。然而,在我们额外的初步研究中,我们发现SR-2B是一种显著的
TNF-α上调(> 30倍)。这种诱导需要BMP-2信号,这可能解释了我们的发现
尽管5-HT增强了TNF-α诱导的钙化,但它本身没有作用。我们还发现
TNF-α/5-HT诱导的钙化通过诱导质膜钙通道Orai 1发生,
这种钙化通过特异性抑制剂或仅SR-2B的敲低而减弱。补充初步
研究表明,高脂血症(ApoE-/-)患者外周血5-HT水平高于正常对照组(P <0.05)。
SR-2B在瓣膜尖的表达与胆固醇裂隙和钙化病变相邻,
ApoE-/-,但在野生型小鼠中没有。基于集体证据,我们假设,5-HT在
高脂血症环境在CAVD中起关键作用。我们认为高脂血症会增加血液循环中的
5-HT和炎性细胞因子,后者诱导SR-2B和瓣尖中的骨生成,以及,
这些事件一起导致CAVD。在目的1中,我们将确定5-HT的受体亚型特异性作用
在非炎症条件下(SR-2A占主导地位)对基质力学的影响以及在炎症条件下对钙化的影响
(SR-2B显性)条件和介导TNF-α诱导SR-2B和SR-2B的信号传导途径。
下游成骨细胞分化。在目标2中,我们将确定经由SR-2B的5-HT信号传导是否是有效的。
使用1)5-HT缺陷的炎性小鼠模型(Tph 1-/-Ldlr-/-
Apob 100/100),和2)受体亚型特异性激动剂和拮抗剂。我们将应用尖端技术,
包括激光光片荧光显微镜;系列体内融合18F-µPET-µCT成像;原子力
显微镜; 3-D水凝胶培养物;和受体亚型敲低细胞的植入。拟议
实验将阐明5-HT受体亚型特异性信号传导如何改变瓣膜尖的结构
以及靶向SR-2B是否为CAVD的有效药物治疗开辟了道路。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Linda L. Demer其他文献
Artery compliance improves after ultrasonic ablation of atherosclerotic lesions
- DOI:
10.1016/0735-1097(90)92133-m - 发表时间:
1990-02-01 - 期刊:
- 影响因子:
- 作者:
Linda L. Demer;Robert J. Siegel - 通讯作者:
Robert J. Siegel
Linda L. Demer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Linda L. Demer', 18)}}的其他基金
Role of intermittent activation of parathyroid hormone receptor in exercise-induced vascular calcification
甲状旁腺激素受体间歇性激活在运动性血管钙化中的作用
- 批准号:
10534138 - 财政年份:2021
- 资助金额:
$ 39万 - 项目类别:
Role of intermittent activation of parathyroid hormone receptor in exercise-induced vascular calcification
甲状旁腺激素受体间歇性激活在运动性血管钙化中的作用
- 批准号:
10320968 - 财政年份:2021
- 资助金额:
$ 39万 - 项目类别:
Serotonin receptor contribution to inflammation-induced calcific aortic valve disease
血清素受体对炎症引起的钙化主动脉瓣疾病的贡献
- 批准号:
10365996 - 财政年份:2019
- 资助金额:
$ 39万 - 项目类别:
Mechanisms of intermittent parathyroid hormone effects on calcific aortic disease
间歇性甲状旁腺激素对钙化性主动脉疾病的作用机制
- 批准号:
9035205 - 财政年份:2015
- 资助金额:
$ 39万 - 项目类别:
Mechanisms of intermittent parathyroid hormone effects on calcific aortic disease
间歇性甲状旁腺激素对钙化性主动脉疾病的作用机制
- 批准号:
8880695 - 财政年份:2015
- 资助金额:
$ 39万 - 项目类别:
Role of Inhibitory SMADs in Calcific Aortic Valve Disease
抑制性 SMAD 在钙化主动脉瓣疾病中的作用
- 批准号:
8535813 - 财政年份:2012
- 资助金额:
$ 39万 - 项目类别:
Role of Inhibitory SMADs in Calcific Aortic Valve Disease
抑制性 SMAD 在钙化主动脉瓣疾病中的作用
- 批准号:
8891481 - 财政年份:2012
- 资助金额:
$ 39万 - 项目类别:
Role of Inhibitory SMADs in Calcific Aortic Valve Disease
抑制性 SMAD 在钙化主动脉瓣疾病中的作用
- 批准号:
8352180 - 财政年份:2012
- 资助金额:
$ 39万 - 项目类别:
Role of Lymphatic Clearance in Lipid-Induced Calcific Vasculopathy and Bone Loss
淋巴清除在脂质引起的钙化性血管病和骨丢失中的作用
- 批准号:
8165115 - 财政年份:2011
- 资助金额:
$ 39万 - 项目类别:
Role of Lymphatic Clearance in Lipid-Induced Calcific Vasculopathy and Bone Loss
淋巴清除在脂质引起的钙化性血管病和骨丢失中的作用
- 批准号:
8308373 - 财政年份:2011
- 资助金额:
$ 39万 - 项目类别:
相似海外基金
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 39万 - 项目类别:
Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 39万 - 项目类别:
Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 39万 - 项目类别:
Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 39万 - 项目类别:
Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 39万 - 项目类别:
Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 39万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 39万 - 项目类别:
Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
- 批准号:
2301846 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别:
Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别:
Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
- 批准号:
23K16076 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别:
Grant-in-Aid for Early-Career Scientists